NCRBF(NCRBF)
NCRBF
No analyst ratings available
No analyst price targets available for NCRBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $39.40B | $40.89B | $41.89B |
| Low | $39.40B | $40.89B | $41.89B |
| High | $39.40B | $40.89B | $41.89B |
| EBITDA Avg | $11.13B | $11.56B | $11.84B |
| Low | $11.13B | $11.56B | $11.84B |
| High | $11.13B | $11.56B | $11.84B |
| EBIT Avg | $6.65B | $6.90B | $7.07B |
| Low | $6.65B | $6.90B | $7.07B |
| High | $6.65B | $6.90B | $7.07B |
| Net Income Avg | $2.54B | $3.46B | $3.66B |
| Low | $2.54B | $3.46B | $3.66B |
| High | $2.54B | $3.46B | $3.66B |
| EPS Avg | $230.12 | $313.00 | $331.40 |
| Low | $230.12 | $313.00 | $331.40 |
| High | $230.12 | $313.00 | $331.40 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $9.75B | $11.92B |
| Low | $9.75B | $11.92B |
| High | $9.75B | $11.92B |
| EBITDA Avg | $2.76B | $3.37B |
| Low | $2.76B | $3.37B |
| High | $2.76B | $3.37B |
| EBIT Avg | $1.65B | $2.01B |
| Low | $1.65B | $2.01B |
| High | $1.65B | $2.01B |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — |